Literature DB >> 28272139

Recent observations on intolerance of dolutegravir: differential causes and consequences.

Mark G J de Boer1, Kees Brinkman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28272139     DOI： 10.1097/QAD.0000000000001395

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  2 in total

1.  Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients.

Authors:  Thomas Theo Brehm; Marleen Franz; Anja Hüfner; Sandra Hertling; Stefan Schmiedel; Olaf Degen; Benno Kreuels; Julian Schulze Zur Wiesch
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

2.  Substance use, Unlike Dolutegravir, is Associated with Mood Symptoms in People Living with HIV.

Authors:  Lisa Van de Wijer; Wouter van der Heijden; Mike van Verseveld; Mihai Netea; Quirijn de Mast; Arnt Schellekens; André van der Ven
Journal:  AIDS Behav       Date:  2021-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.